PARALLAX
A 24-week, study to evaluate the effect of LCZ696 on NT-proBNP, symptoms, exercise function and safety compared to individualized medical management of comorbidities in patients with heart failure and preserved ejection fraction
- Stadium
- klaar
- Middel
- Entresto
- Populatie
- Hartfalen
- Fase
- III
- First Patient In
- 8 januari 2018
- Last Patient In
- 7 mei 2019
- Last Patient Last Visit
- 31 oktober 2019
National Lead
